Found 202 articles for: "chemotherapy"
An Extensive Presentation of Cutaneous Angiosarcoma
August 2021 | Volume 20 | Issue 8 | Case Reports | 895 | Copyright © August 2021
In this report, the case of a 58-year-old male with extensive, rapidly growing cutaneous angiosarcoma is described. Though involvement of the scalp is common in cutaneous angiosarcoma, the extent of c...
Read MoreHand Foot Skin Reaction Associated With Palbociclib
July 2021 | Volume 20 | Issue 7 | Case Reports | 783 | Copyright © July 2021
Palbociclib is one of three new small-molecule inhibitors of cyclin-dependent kinase 4 and 6 (CDK4/6) approved for use in the treatment of hormone receptor positive (HR+) and human epidermal growth fa...
Read MoreCell-Free Blood Cell Secretome (BCS) Counteracts Skin Aging and Restores Firmness and Elasticity
June 2021 | Volume 20 | Issue 6 | Original Article | 682 | Copyright © June 2021
Background: Blood Cell Secretome, BCS (also Autologous Conditioned Serum, ACS) is efficacious in treatment of musculoskeletal disorders. It contains inflammation resolving cytokines, ...
Read MoreBridging the Gap: Integrating Gene Expression Profiling into Clinical Practice
June 2021 | Volume 20 | Issue 6 | Supplement Individual Articles | s4 | Copyright © June 2021
Treatment Update of Port-Wine Stain: A Narrative Review
May 2021 | Volume 20 | Issue 5 | Original Article | 515 | Copyright © May 2021
Background: Port-wine stain (PWS) is a congenital vascular malformation affecting 0.3–0.5% of normal population. These characteristic lesions arise due to the interplay of vascu...
Read MoreAssessing the Risk of Apremilast Use for Psoriasis During the COVID-19 Pandemic
May 2021 | Volume 20 | Issue 5 | Editorials | 582 | Copyright © May 2021
Assessing the Risk of Apremilast Use for Psoriasis During the COVID-19 Pandemic.
Apremilast, a phosphodiest...
Read MoreA Case of Cutaneous Blastic Plasmacytoid Dendritic Cell Neoplasm Treated With a Bcl-2 Inhibitor
May 2021 | Volume 20 | Issue 5 | Case Reports | 550 | Copyright © May 2021
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive primary cutaneous lymphoma characterized by transformed plasmacytoid dendritic cells that overexpress interleukin-3 recept...
Read MorePanitumumab-Related Eyelash Elongation in a Patient With Metastatic Gastrointestinal Carcinoma
April 2021 | Volume 20 | Issue 4 | Features | 478 | Copyright © April 2021
A Non-Surgical and Cost-Effective Treatment Approach Employing Topical Imiquimod, 5-Fluorouracil, and Tretinoin for Primary Non-Melanoma Skin Cancers
March 2021 | Volume 20 | Issue 3 | Original Article | 260 | Copyright © March 2021
Background: Minimally invasive alternative approaches to treat non-melanoma skin cancers remain limited and unproven.
Objective: We aim to assess the efficacy o...
Read MoreIntralesional 5-Fluorouracil for Treatment of Non-Melanoma Skin Cancer: A Systematic Review
February 2021 | Volume 20 | Issue 2 | Original Article | 192 | Copyright © February 2021
Background: Surgical excision is the paradigm treatment option for non-melanoma skin cancer (NMSC), however intralesional fluorouracil (IL 5-FU) is an efficacious alternative and supe...
Read MoreA Review of Hedgehog Inhibitors Sonidegib and Vismodegib for Treatment of Advanced Basal Cell Carcinoma
February 2021 | Volume 20 | Issue 2 | Original Article | 156 | Copyright © February 2021
Basal cell carcinoma (BCC) is the most common malignancy in fair-skinned populations. Most cases are successfully treated with surgery, but in advanced BCC—including locally advanced BCC and met...
Read MoreDo Antimicrobial Resistance Patterns Matter? An Algorithm for the Treatment of Patients With Impetigo
February 2021 | Volume 20 | Issue 2 | Original Article | 134 | Copyright © February 2021
Background: Impetigo, a highly contagious bacterial skin infection commonly occurring in young children, but adults may also be affected. The superficial skin infection is mainly caus...
Read MoreTherapies for Psoriasis: Clinical and Economic Comparisons
November 2020 | Volume 19 | Issue 11 | Original Article | 1101 | Copyright © November 2020
Background: Clinical and economic comparisons of therapies for plaque psoriasis are regularly updated following each new devel- opment in the field. With the recent availability of a ...
Read MoreGrover Disease Associated With Chemotherapy: Review of Potential Pathophysiology, Current Treatments, and Future Directions
November 2020 | Volume 19 | Issue 11 | Original Article | 1056 | Copyright © November 2020
Introduction: Transient acantholytic dermatosis has been frequently reported in patients with malignancies. While paraneoplastic cases have rarely been reported, most eruptions occur ...
Read MoreARTICLE: Colloidal Oatmeal Part II: Atopic Dermatitis in Special Populations and Clinical Efficacy and Tolerance Beyond Eczema
October 2020 | Volume 19 | Issue 10 | Supplement Individual Articles | s8 | Copyright © October 2020
Colloidal oatmeal has a diverse array of applications, clinical benefits, and uses beyond atopic dermatitis. First and foremost, it has been shown to be of benefit in the treatment of atopic dermatiti...
Read MoreHyaluronidase in Dermatology: Uses Beyond Hyaluronic Acid Fillers
October 2020 | Volume 19 | Issue 10 | Original Article | 993 | Copyright © October 2020
Hyaluronidase is mostly widely recognized for its off-label use in correction of complications of hyaluronic acid fillers. However, its utility in other aspects of dermatology is less widely acknowled...
Read MoreHalobetasol Propionate Lotion 0.01% for Moderate-to-Severe Plaque Psoriasis: Pooled Analysis in Male and Female Participants
August 2020 | Volume 19 | Issue 8 | Original Article | 747 | Copyright © August 2020
Introduction: Psoriasis is a chronic, immune-mediated skin disease that is associated with sex-related differences. Two double-blind, vehicle-controlled, phase 3 studies evaluated hal...
Read MoreThe Influence of Supportive Oncodermatology Interventions on Patient Quality of Life: A Cross-Sectional Survey
May 2020 | Volume 19 | Issue 5 | Original Article | 477 | Copyright © May 2020
Background: Dermatologic adverse events (dAEs) secondary to anticancer treatments reduce patients’ quality of life (QOL) and result in interruptions in anticancer therapy.
Read MoreTopical Fluorouracil Therapy for Residual Superficial Basal Cell Carcinoma Following Mohs Micrographic Surgery
May 2020 | Volume 19 | Issue 5 | Original Article | 485 | Copyright © May 2020
When treating invasive basal cell carcinoma (BCC) with Mohs micrographic surgery (MMS), including infiltrative and nodular subtypes, the goal is complete surgical removal of the tumor. In some cases, ...
Read MoreRisk of Non-Melanoma Skin Cancer in Connective Tissue Disease and The Impact of Immunosuppressive Therapy
May 2020 | Volume 19 | Issue 5 | Original Article | 519 | Copyright © May 2020
The risk of skin cancer in connective tissue disease and the impact of immunosuppressive therapy on this risk has not been well studied. The objective of this study is to investigate the risk of non-m...
Read More